AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

Viking Therapeutics Inc. (VKTX)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

33.64

0.18 (0.54%)

At close: Jan 28, 2025, 1:56 PM

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.

Boring Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	292.00K	291.00K	296.00K	277.00K	260.00K	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit	-292.00K	-291.00K	-296.00K	-277.00K	-260.00K	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Income	-100.83M	-70.36M	-55.68M	-42.66M	-32.69M	-26.16M	-19.07M	-13.85M	-12.00M	-23.47M	-101.08K	-438.56
Interest Income	15.02M	1.59M	703.00K	3.23M	7.05M	3.24M	1.27K	n/a	n/a	n/a	n/a	5.54
Pretax Income	-85.89M	-68.87M	-54.99M	-39.49M	-25.78M	-22.06M	-20.58M	-14.73M	-23.40M	-21.88M	-146.25K	-444.11
Net Income	-85.89M	-67.38M	-54.00M	-36.05M	-25.78M	-22.06M	-20.58M	-14.73M	-23.40M	-21.88M	-146.25K	-444.11
Selling & General & Admin	37.02M	16.12M	10.70M	10.73M	9.13M	7.12M	5.33M	4.85M	5.03M	1.24M	89.46K	163.08
Research & Development	63.81M	54.23M	44.98M	31.93M	23.56M	19.04M	13.74M	9.00M	6.97M	22.22M	11.61K	275.48
Other Expenses	n/a	n/a	n/a	n/a	n/a	1.40M	344.93K	1.06M	-10.43M	2.21M	-20.62K	n/a
Operating Expenses	100.83M	70.36M	55.68M	42.66M	32.69M	26.16M	19.07M	13.85M	12.00M	23.47M	101.08K	438.56
Interest Expense	88.00K	n/a	18.00K	106.00K	146.00K	404.00K	1.28M	1.81M	982.18K	628.68K	24.55K	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	100.83M	70.36M	55.68M	42.66M	32.69M	26.16M	19.07M	13.85M	12.00M	23.47M	101.08K	438.56
Income Tax	n/a	-1.49M	-988.00K	-3.44M	6.99M	-2.71M	1.85M	1.95M	982.18K	628.68K	24.55K	-5.54
Shares Outstanding (Basic)	94.35M	76.83M	77.20M	72.60M	71.96M	57.58M	25.98M	16.28M	6.36M	4.31M	4.31M	1.48K
Shares Outstanding (Diluted)	94.35M	76.83M	77.20M	72.60M	71.96M	57.58M	25.98M	16.28M	6.36M	4.31M	4.31M	1.48K
EPS (Basic)	-0.91	-0.88	-0.7	-0.5	-0.36	-0.38	-0.79	-0.9	-3.68	-5.08	-0.03	-0.3
EPS (Diluted)	-0.91	-0.88	-0.7	-0.5	-0.36	-0.38	-0.79	-0.9	-3.68	-5.08	-0.03	-0.3
EBITDA	-100.83M	-70.36M	-55.39M	-42.66M	-25.37M	4.66M	442.88K	1.15M	-22.39M	-21.26M	-121.70K	-109.64K
Depreciation & Amortization	292.00K	291.00K	296.00K	277.00K	260.00K	26.16M	19.07M	13.85M	-10.43M	2.21M	-20.62K	438.56